Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTAMA general use-results survey in atopic dermatitis
jRCT2031250236Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tapinarof in atopic dermatitis (AD), sponsored by Shionogi & Co., Ltd. Primary endpoints: Incidence of onset of adverse drug reactions, Incidence of skin symptoms at the application site and 1 more. Started Jul 2025; status: recruiting.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2031250236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250236.